Expectorants are the medical agents that help prevent or bring up mucus from the lungs, bronchi, and trachea. They increase the drainage of mucus from the lungs by thinning the mucus and reducing the respiratory tract's irritation by lubrication. They also help to relieve chest congestion caused by cold, allergies, and flu.
MARKET DYNAMICS
Expectorants market is driving due to the growing dry cough cases, which causes dryness, easy availability of expectorants OTC drugs, and rising prevalence of respiratory diseases. However, adverse reactions to the overdose of cough syrups and lack of good pharmacokinetics of drugs will hamper the market's growth. Moreover, the rising prevalence of cold and cough in children worldwide and emerging markets are expected to provide opportunities in the global Expectorants market.
MARKET SCOPE
The "Expectorants Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of expectorants market with detailed market segmentation by product type, route of administration and end user. The expectorants market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in expectorants market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The expectorants market is segmented on the basis of product type, route of administration, and end user. Based on type, the market is segmented as drug, OTC, herbal, and others. Based on route of administration, the market is segmented as oral, inhalational, others. Based on end user, the market is segmented as hospitals, specialty clinics, others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the expectorants market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The expectorants market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting expectorants market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Expectorants market in these regions.
MARKET PLAYERS
The report covers key developments in the Expectorants market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Expectorants market are anticipated to have lucrative growth opportunities in the future with the rising demand for Expectorants in the global market. Below mentioned is the list of few companies engaged in the Expectorants market.
The report also includes the profiles of key players in Expectorants market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Boehringer Ingelheim International GmbH
- ACADIA Pharmaceuticals Inc.
- Perrigo Company plc
- Reckitt Benckiser Group plc
- Teva Pharmaceutical Industries Ltd.
- Amneal Pharmaceuticals LLC
- Aurobindo Pharma
- Vertical Pharmaceuticals
- Johnson & Johnson
- Toray Industries
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.